Lämmler C
Institut für Bakteriologie und Immunologie, Justus-Liebig-Universität Giessen, Federal Republic of Germany.
Zentralbl Bakteriol Mikrobiol Hyg A. 1988 Aug;269(2):237-44. doi: 10.1016/s0176-6724(88)80101-9.
Certain group L streptococci demonstrate surface receptors for human albumin. Binding of 125I-albumin to group L streptococci could be inhibited by unlabelled albumin preparations from humans, dogs, mice and bovines, but not by albumin from rabbits. The albumin-binding proteins (ABP) could be solubilized from the streptococcal surface by hot acid treatment of the bacteria and isolated by affinity chromatography on human-albumin sepharose. ABP and specific antisera produced against ABP inhibited 125I-albumin binding to group L streptococci. The molecular weight of ABP determined by SDS-PAGE and Western blotting, was approximately 48,000 Dalton. ABP preparations of group G streptococci isolated from bovines and humans demonstrated cross reactivity with antiserum produced against group L streptococcal ABP.
某些L群链球菌表现出对人白蛋白的表面受体。125I标记的白蛋白与L群链球菌的结合可被来自人、狗、小鼠和牛的未标记白蛋白制剂抑制,但不能被来自兔子的白蛋白抑制。通过对细菌进行热酸处理可从链球菌表面溶解白蛋白结合蛋白(ABP),并通过在人白蛋白琼脂糖上的亲和色谱法进行分离。ABP和针对ABP产生的特异性抗血清可抑制125I标记的白蛋白与L群链球菌的结合。通过SDS-PAGE和蛋白质印迹法测定的ABP分子量约为48,000道尔顿。从牛和人中分离出的G群链球菌的ABP制剂与针对L群链球菌ABP产生的抗血清表现出交叉反应性。